(2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile

We are (2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile CAS:196597-79-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile
CAS.NO:196597-79-2
Synonyms:(2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile
(2E)-1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylideneethanenitrile
(1,2,6,7-Tetrahydro-3-oxa-as-indacen-8-ylidene)-acetonitrile
2-(1,2,6,7-tetrahydro-8H-indeno[5,4-b]furan-8-ylidene)acetonitrile
(E)-2-(6,7-Dihydro-1H-indeno[5,4-b]furan-8(2H)-ylidone)Acetonitrile
 
Physical and Chemical Properties:
Density 1.321±0.06 g/cm3
Boiling Point 392.1±21.0 °C at 760 mmHg
Melting Point 146-151 ºC
Molecular Formula C13H11NO
Molecular Weight 197.232
Flash Point 165.0±15.9 °C
 
Specification:
Appearance:White to yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Ramelteon(CAS:196597-26-9).

(2E)-2-(1,2,6,7-tetrahydrocyclopenta[e][1]benzofuran-8-ylidene)acetonitrile


Related News: The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said.3′-cloroacetofenona CAS:99-02-5 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.sodium,4-chloro-1-hydroxybutane-1-sulfonate CAS:54322-20-2 Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.4-Amino-N-Boc-L-Phenylalanine In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.

Related Products
Product Name
4-Amino-3-fluoropyridine View Details
2,4-Bis(trifluoromethyl)aniline View Details
Ethanethiol View Details
(2-bromo-5-fluorophenyl)methanol manufacturer 2-(Trifluoromethoxy)benzoic acid manufacturer [amino(phosphono)methyl]phosphonic acid manufacturer ancitabine hydrochloride manufacturer O-tert-butyl-D-serine methyl ester hydrochloride manufacturer